Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000497889 | SCV000589489 | likely pathogenic | not provided | 2015-10-15 | criteria provided, single submitter | clinical testing | The G122S variant in the PDHA1 gene has been reported previously in a male patient with hypotonia, ventriculomegaly, infantile spasms and developmental delay; data showed this male individual to be heterozygous for G122S, which is suggestive of somatic mosaicism (Kutty et al., 2014). The G122S variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The G122S variant is a non-conservative amino acid substitution, which occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in nearby residues (R119W, H121Q, R127W, R127Q) have been reported in the Human Gene Mutation Database in association with pyruvate dehydrogenase deficiency (Stenson et al., 2014), supporting the functional importance of this region of the protein. The G122S variant is a strong candidate for a pathogenic variant. |